Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Optic Nerve Glioma 1Neoplasms, Unknown Primary 1Gliosarcoma 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Astrocytoma 1

Interventions

Temozolomide 3Bevacizumab 3Re-Irradiation 2Nivolumab 2Irinotecan 2Cetuximab 2ribociclib 1pembrolizumab 1lutetium Lu 177 dotatate 1dostarlimab 1dipinacoline glutamate 1dinutuximab 1cemiplimab 1abemaciclib 1Vorinostat 1Vincristine 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Mebendazole 1Maintenance 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluid Therapy 1Eflornithine 1Congresses as Topic 1Carboplatin 1CBLC137 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Diffuse Intrinsic Pontine Glioma × Mebendazole × Clear all
NCT01837862 2024-07-05

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

Northwell Health

Phase 1/2 Completed
36 enrolled
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Glioma, Gliosarcoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡